1Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
*Corresponding Author: Thananya Boonyasirinant E-mail: drthananyaa@yahoo.com
Received 22 October 2025 Revised 13 November 2025 Accepted 13 November 2025 ORCID ID:http://orcid.org/0000-0002-9149-3407 https://doi.org/10.33192/smj.v78i1.278423
All material is licensed under terms of the Creative Commons Attribution 4.0 International (CC-BY-NC-ND 4.0) license unless otherwise stated.
ABSTRACT
Objective: Left atrial enlargement (LAE) is common in cardiovascular disease and is associated with heart failure, atrial fibrillation, and stroke. Chest X-ray (CXR) is widely available; however, its diagnostic value for LAE has not been validated against cardiac magnetic resonance imaging (CMR). We evaluated the correlation and diagnostic performance of conventional CXR signs for detecting LAE using CMR as the reference standard.
Materials and Methods: We retrospectively analyzed 110 patients who underwent CMR and had a posteroanterior CXR within 6 months. Left atrial volume was calculated by the biplane area–length method and indexed to body surface area. CXR signs assessed were the subcarinal angle, double density sign, and left atrial appendage prominence (“third contour”). Sensitivity, specificity, and diagnostic accuracy were calculated against CMR-defined LAE. Results: CMR identified LAE in 85 patients (77.3%). The third contour had the highest sensitivity (78.8%) but poor specificity (8.0%), whereas a subcarinal angle > 90° had the highest specificity (92.0%) with low sensitivity (8.2%). Overall diagnostic accuracy for individual or combined CXR signs was 27.3%–62.7%, with no correlation between CXR findings and CMR-derived left atrial volume index (all P > 0.05).
Conclusions: To our knowledge, this is the first study validating CXR parameters against CMR for detecting LAE, revealing that conventional radiographic signs have limited diagnostic performance. Despite its accessibility and routine use, CXR demonstrated low sensitivity and specificity for LAE compared with CMR.
Keywords: Left atrial enlargement; cardiac magnetic resonance imaging; chest X-ray (Siriraj Med J 2026;78(1):29-38)
INTRODUCTION
Left atrial enlargement (LAE) is common across cardiovascular conditions, including heart failure, valvular heart disease, and atrial fibrillation.1,2 It also occurs in disorders linked to cardiovascular pathology, such as hypertension, obesity, and obstructive sleep apnea.3,4
LAE can be assessed with chest X-ray (CXR), electrocardiogram (ECG), echocardiography, cardiac magnetic resonance (CMR), or cardiac computed tomography (CT). Despite limitations, CXR remains simple, accessible, and widely used.5,6 Radiographic criteria include measuring the subcarinal angle, evaluating left atrial prominence along the left heart border (“third contour”), and identifying the double density sign. CMR provides highly precise chamber quantification, including the left atrium, right atrium, left ventricle, and right ventricle.7-9
LAE is strongly associated with increased risk of heart failure, stroke, and atrial fibrillation, as well as elevated cardiovascular mortality.10-13 Consequently, accurate left atrial sizing is essential for risk stratification, outcome prediction, and disease monitoring.
Prior studies have compared LAE assessment by electrocardiogram with CMR14,15, but none have directly compared CXR with CMR. Therefore, we investigated the diagnostic performance of conventional CXR signs for detecting LAE, using CMR as the reference standard.
MATERIALS AND METHODS
Study population
We consecutively enrolled 110 patients who underwent CMR at the Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Eligibility required a posteroanterior upright CXR of adequate quality performed within 6 months before or after the CMR examination. Patients with significant valvular heart disease, post-cardiothoracic surgery, or pulmonary conditions affecting lung volume (such as atelectasis or pleural effusion) were excluded. Baseline clinical characteristics and medical history were obtained from medical records. The study protocol was approved by the Siriraj Institutional Review Board.
CMR acquisition and measurements
Acquisition
CMR examinations were performed on a 1.5T Achieva XR scanner (Philips, Best, Netherlands). After localizer scouts, cine steady-state free precession balanced turbo field echo images were obtained in 2-, 3-, and 4-chamber and short-axis views. Imaging parameters were: repetition time/echo time/number of excitations,
3.7/1.8/1; slice thickness, 8 mm with no gap; flip angle, 60°; and 25 cardiac phases per cardiac cycle. Field of view was 350×320 mm for long-axis and 270×320 mm for short-axis views, with reconstructed voxel size 1.25×1.25×8 mm³
Left atrial volume measurement and indexing
CMR images were analyzed offline using cardiovascular imaging software (Extended Brilliance Workspace; Philips Healthcare, Best, Netherlands). The left atrial volume was derived with the biplane area–length method at end-atrial diastole, including the left atrial appendage and excluding the 4 pulmonary veins. The left atrial area was manually contoured on mid-atrial slices in 2- and 4-chamber cine views. The atrioventricular junction was defined by a line connecting the mitral valve insertion points. The atrial long-axis length was measured as the perpendicular distance from the midpoint of the mitral annular plane to the superior left atrial border. Left atrial volume (LAV) was calculated by the biplane area–length formula:
LAV = (8 × A₁ × A₂) / (3π × L).
A₁ and A₂ denote maximal planimetered left atrial areas from the vertical and horizontal long-axis views, and L denotes the long-axis length. The LAV index (LAVI) was obtained by normalizing LAV to body surface area.
Reproducibility and additional left ventricular metrics To assess intra- and interobserver variability, the primary investigator repeated measurements after 1 week in 20 randomly selected patients; an independent investigator performed the same measurements. Left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), left ventricular ejection fraction (LVEF), and left ventricular mass index were
measured according to current guidelines.
CXR acquisition and measurements
CXRs were performed using standard technique with posteroanterior projection. Patients with uninterpretable films owing to inappropriate exposure, severe kyphoscoliosis, severe pulmonary disease, or inadequate inspiration were excluded. Three left atrial enlargement signs were evaluated: left atrial appendage prominence (“third contour”), double density sign, and subcarinal angle. Third contour was defined as protrusion of the left heart border between the left pulmonary artery and the ventricular border, graded as 1+ (slight protrusion) or 2+ (obvious protrusion). The double density sign was a curvilinear line along the right heart border with a distance from the mid-inferior left bronchus to that border > 7 cm. The subcarinal angle was measured on a dedicated workstation.
Analyses were performed with PASW Statistics version 18 (SPSS Inc, Chicago, IL, USA). Categorical variables are
presented as counts and percentages; continuous variables are expressed as mean (SD) for normally distributed data and median (IQR) for nonnormally distributed data. Normality was assessed with the Kolmogorov–Smirnov test. We calculated accuracy, sensitivity, specificity, positive and negative likelihood ratios, and positive and negative predictive values for each criterion and for all 3 combined, using CMR-derived LAVI as the reference. Group comparisons used the chi-square test or Fisher’s exact test for categorical variables, and Student’s t test or the Mann–Whitney U test for continuous variables, as appropriate. A P value < 0.05 was considered statistically significant.
RESULTS
Baseline characteristics
A total of 110 patients were included in the analysis. The mean age was 68.8 ± 10.1 years, and 40.0% were male. Mean body mass index and body surface area were 25.8 ± 4.8 kg/m² and 1.67 ± 0.20 m², respectively. Hypertension, dyslipidemia, diabetes mellitus, and coronary artery disease were present in 87.3%, 83.6%, 42.7%, and 36.4%, respectively. Current smoking was reported in 16.4% of participants. The mean systolic and diastolic blood pressures were 137.0 ± 21.3 mm Hg and 68.0 ±
11.3 mm Hg, respectively (Table 1).
CMR findings
CMR demonstrated a median LVEDV of 122.8 mL (IQR 101.8–154.4 mL) and a median LVESV of 36.8 mL (IQR 23.3–56.5 mL). The mean LVEF was 65.9%
± 16.6%, and the mean LAVI was 52.6 ± 17.8 mL/m² (Table 2). Using cutoffs of LAVI > 40 mL/m² for men and
39 mL/m² for women, LAE was present in 85 patients (77.3%). Among CMR-derived volumetric parameters, LAVI correlated significantly with LVEDV but not with LVESV or LVEF.
CXR findings
On CXR, a third contour was presented in 81.8% of patients (score 1+ to 2+), whereas 18.2% had no visible contour (score 0). A prominent third contour (score 2+) was identified in 20.9% of patients, and a double density sign in 13.6% of patients. The mean subcarinal angle was 73.4 ± 11.7°, with 42.7% exceeding 75° and
8.2% exceeding 90°.
Using subcarinal angle thresholds of > 75° and > 90°, the presence of any radiographic criterion (third contour, double density sign, or widened subcarinal angle) was noted in 88.2% and 82.7% of patients, respectively. The combined presence of all 3 findings was detected in
TABLE 1. Baseline characteristics.
Variables | Values | LAVI > 40 mL/m2 in men or >39 mL/m2 in women (n = 85) | LAVI ≤ 40 mL/m2 in men or ≤ 39 mL/m2 in women (n = 25) | p - value |
Age (years) | 68.8 ± 10.1 | 70.0 ± 10.1 | 64.9 ± 9.4 | 0.028 |
Male gender | 44 (40.0%) | 35 (41.2%) | 9 (36.0%) | 0.642 |
Height (cm) | 157.7 ± 8.6 | 156.8 ± 8.7 | 160.8± 7.8 | 0.042 |
Weight (kg) | 64.2 ± 13.7 | 64.2 ± 12.9 | 64.1 ± 16.5 | 0.966 |
Body mass index (kg/m2) | 25.8 ± 4.8 | 26.1 ± 4.6 | 24.7 ± 5.3 | 0.191 |
Body surface area (m2) | 1.7 ± 0.2 | 1.7 ± 0.2 | 1.7 ± 0.2 | 0.720 |
Systolic BP (mmHg) | 137.0 ± 21.3 | 140.0 ± 21.4 | 127.0 ± 17.9 | 0.007 |
Diastolic BP (mmHg) | 68.0 ± 11.7 | 67.7 ± 11.5 | 69.3 ± 10.4 | 0.533 |
Hypertension | 96 (87.3%) | 78 (91.8%) | 18 (72.0%) | 0.016 |
Dyslipidemia | 92 (83.6%) | 77 (90.6%) | 15 (60.0%) | 0.001 |
Diabetes mellitus | 47 (42.7%) | 36 (42.4%) | 11 (44.0%) | 0.884 |
Coronary artery disease | 40 (36.4%) | 33 (38.8%) | 7 (28.0%) | 0.323 |
Smoking | 18(16.4%) | 13 (15.3%) | 5 (20.0%) | 0.552 |
Data are mean ± SD or n (%).
Abbreviations: LV = left ventricular; LAVI = left atrial volume index; cm = centimeter; kg = kilogram; BP = blood pressure; mL = milliliter; mL/m2 = milliliter per square meter
TABLE 2. CMR-derived left ventricular and left atrial parameters.
Variables | Values | LAVI > 40 mL/m2 in men or >39 mL/m2 in women (n = 85) | LAVI ≤ 40 mL/m2 in men or ≤ 39 mL/m2 in women (n = 25) | p - value |
LV end diastolic volume (ml) | 122.8 (101.8 - 154.4) | 135.0 (104.5-155.5) | 106.7 (87.0-121.1) | 0.001 |
LV end systolic volume (ml) | 36.8 (23.3 - 56.5) | 40.5 (25.5-59.7) | 30.4 (18.7-43.5) | 0.052 |
LV ejection fraction (%) | 65.9 ± 16.6 | 65.3 ± 17.2 | 67.7 ± 14.3 | 0.525 |
LA volume index (ml/m2) | 52.6 ± 17.8 | 58.8 ± 15.2 | 31.8 ± 6.3 | - |
Data are mean ± SD or median (percentile 25th – percentile 75th).
Abbreviations: LV = left ventricular; LA = left atrial; LAVI = left atrial volume index; mL = milliliter; mL/m2 = milliliter per square meter
9.1% of patients for the > 75° threshold and in 3.6% for the stricter > 90° threshold (Table 3). None of the CXR parameters—including third contour, double density sign, or subcarinal angle thresholds—correlated significantly with CMR-defined LAE (all P > 0.05).
Diagnostic performance of CXR parameters
The diagnostic performance of CXR parameters for detecting LAE (LAVI > 40 mL/m² in men and > 39 mL/m² in women) is summarized in Table 4.
When evaluated individually, the presence of a
TABLE 3. Radiographic characteristics of chest X-ray findings.
Variables | Values | LAVI > 40 mL/m2 in men or >39 mL/m2 in women (n = 85) | LAVI ≤ 40 mL/m2 in men or ≤ 39 mL/m2 in women (n = 25) | p - value | |
3rd Contour | |||||
0 | 20 (18.2%) | 18 (21.2%) | 2 (8.0%) | 0.285 | |
1 | 67 (60.9%) | 49 (57.6%) | 18 (72.0%) | ||
2 | 23 (20.9%) | 18 (21.2%) | 5 (20.0%) | ||
3rd Contour | |||||
0 | 20 (18.2%) | 18 (21.2%) | 2 (8.0%) | 0.236 | |
1 - 2 | 90 (81.8%) | 67 (78.8%) | 23 (92.0%) | ||
3rd Contour | |||||
0 - 1 | 87 (79.1%) | 67 (78.8) | 20 (80.0%) | 0.899 | |
2 | 23 (20.9%) | 18 (21.2%) | 5 (20.0%) | ||
Double density sign | |||||
0 | 95 (86.4%) | 75 (88.2%) | 20 (80.0%) | 0.325 | |
1 | 15 (13.6%) | 10 (11.8%) | 5 (20.0%) | ||
Subcarinal angle | 73.35 ± 11.67 | 73.41 ± 11.57 | 73.16 ± 12.27 | 0.925 | |
≤ 75 | 63 (57.3%) | 50 (58.8%) | 13 (52.0%) | 0.544 | |
> 75 | 47 (42.7%) | 35 (41.2%) | 12 (48.0%) | ||
≤ 90 | 101 (91.8%) | 78 (91.8%) | 23 (92.0%) | 1.00 | |
> 90 | 9 (8.2%) | 7 (8.2%) | 2 (8.0%) | ||
Subcarinal angle >75 & Double density sign & 3rd Contour | |||||
0 1 | 100 (90.9%) 10 (9.1%) | 78 (91.8%) 7 (8.2%) | 22 (88.0%) 3 (12.0%) | 0.692 | |
Subcarinal angle >90 & | Double density sign & 3rd | Contour | |||
0 1 | 106 (96.4%) 4 (3.6%) | 82 (96.5%) 3 (3.5%) | 24 (96.0%) 1 (4.0%) | 1.00 | |
Subcarinal angle >75 or | Double density sign or 3rd | Contour | |||
0 1 | 13 (11.8%) 97 (88.2%) | 12 (14.1%) 73 (85.9%) | 1 (4.0%) 24 (96.0%) | 0.291 | |
Subcarinal angle >90 or Double density sign or 3rd Contour | |||||
0 | 19 (17.3%) | 17 (20.0%) | 2 (8.0%) | 0.232 | |
1 | 91 (82.7%) | 68 (80.0%) | 23 (92.0%) | ||
Abbreviations: LAVI = left atrial volume index; cm = centimeter; mL = milliliter; mL/m2 = milliliter per square meter
TABLE 4. Diagnostic performance of CXR parameters compared with CMR-defined LAE.
Variables | Sensitivity | Specificity | LR+ | LR- | PPV (%) | NPV (%) | Accuracy |
(95% CI) | (95% CI) | (95% CI) | (95% CI) | (95% CI) | (95%CI) | (95% CI) | |
3rd Contour (1 – 2) | |||||||
Xxx | 78.8% | 8.0% | 0.9% | 2.7% | 74.4% | 10.0% | 62.7% |
xxx | (68.6-86.9) | (1.0-26.0) | (0.7-1.0) | (0.7-10.6) | (64.2-83.1) | (1.2-31.7) | (53.7-71.8) |
3rd Contour (2) | |||||||
Xxx | 21.2% | 80.0% | 1.1% | 1.0% | 78.3% | 23.0% | 34.6% |
xxx | (13.1-31.4) | (59.3-93.2) | (0.4-2.6) | (0.8-1.2) | (56.3-92.5) | (14.6-33.2) | (25.7-43.4) |
Double density sign | |||||||
Xxx | 11.8% | 80.0% | 0.6% | 1.1% | 66.7% | 21.1% | 27.3% |
xxx | (5.8-20.6) | (59.3-93.2) | (0.2-1.6) | (0.9-1.4) | (38.4-88.2) | (13.4-30.6) | (19.0-35.6) |
Subcarinal angle | |||||||
> 75 | 41.2% | 52.0% | 0.9% | 1.1% | 74.6% | 20.6% | 43.6% |
(30.6-52.4) | (31.3-72.2) | (0.5-1.4) | (0.8-1.7) | (59.7-86.1) | (11.5-32.7) | (34.4-52.9) | |
> 90 | 8.2% | 92.0% | 1.0% | 1.0% | 77.8% | 22.8% | 27.3% |
(3.4-16.2) | (74.0-99.0) | (0.2-4.7) | (0.9-1.1) | (40.0-97.2) | (15.0-32.2) | (19.0-35.6) | |
Subcarinal angle >75 & Double density sign & 3rd Contour | |||||||
Xxx | 8.2% | 88.0% | 0.7% | 1.0% | 70.0% | 22.0% | 11.8% |
xxx | (3.4-16.2) | (68.8-97.5) | (0.2-2.5) | (0.9-1.2) | (34.8-93.3) | (14.3-31.4) | (5.8-17.9) |
Subcarinal angle >90 & Double density sign & 3rd Contour | |||||||
Xxx | 3.5% | 96.0% | 0.9% | 1.0% | 75.0% | 22.6% | 24.6% |
xxx | (0.7-10.0) | (79.6-99.9) | (0.1-8.1) | (0.9-1.1) | (19.4-99.4) | (15.1-31.8) | (16.5-32.6) |
Subcarinal angle >75 or Double density sign or 3rd Contour | |||||||
Xxx | 85.9% | 4.0% | 0.9% | 3.5% | 75.3% | 7.7% | 67.3% |
xxx | (76.6-92.5) | (0.1-20.4) | (0.8-1.0) | (0.5-25.8) | (65.5-83.5) | (0.2-36.0) | (58.5-76.0) |
Subcarinal angle >90 or Double density sign or 3rd Contour | |||||||
Xxx | 80.0% | 8.0% | 0.9% | 2.5% | 74.7% | 10.5% | 63.6% |
xxx | (69.9-87.9) | (1.0-26.0) | (0.7-1.0) | (0.6-10.1) | (64.5-83.3) | (1.3-33.1) | (54.7-72.6) |
third contour showed the highest sensitivity, 78.8% (95% CI, 68.6–86.9), but very low specificity, 8.0% (95% CI, 1.0–26.0). Conversely, a subcarinal angle > 90° provided the highest specificity, 92.0% (95% CI, 74.0–99.0), but
poor sensitivity, 8.2% (95% CI, 3.4–16.2). Using a lower threshold, subcarinal angle > 75° showed moderate sensitivity, 41.2% (95% CI, 30.6–52.4), and specificity,
52.0% (95% CI, 31.3–72.2). The double density sign
demonstrated low sensitivity, 11.8% (95% CI, 5.8–20.6),
but good specificity, 80.0% (95% CI, 59.3–93.2). Overall diagnostic accuracy was 27.3%–62.7%, indicating poor discriminative ability of CXR markers for CMR-defined LAE.
Combining all 3 criteria (subcarinal angle > 75°, double density sign, and third contour) yielded a sensitivity of 8.2% with specificity of 88.0%. Using a stricter combination with subcarinal angle > 90° further decreased sensitivity to 3.5% while achieving specificity to 96.0%.
Clinical predictors of left atrial enlargement
Patients were stratified by CMR-defined LAE (LAVI
40 mL/m² in men and > 39 mL/m² in women). Those with LAE were older than those without LAE (70.0 ± 10.1 vs 64.9 ± 9.4 years; P = 0.028) and had higher systolic blood pressure (140.0 ± 21.4 vs 127.0 ± 17.9 mm Hg; P = 0.007). No significant differences were seen in sex, body mass index, or other cardiovascular risk factors between groups, except for associations between body mass index and the presence of a third contour or subcarinal angle
90° (Table 5).
DISCUSSION
To our knowledge, this is the first study to evaluate CXR for diagnosing LAE using CMR as the reference standard. The prevalence of LAE was high (77.3%), likely reflecting a high burden of comorbidity, particularly hypertension. Prior studies have demonstrated links between elevated blood pressure and higher LAVI.16-18 Among CXR signs, the third contour was most prevalent. Prominent left atrial appendage, double density sign, and subcarinal angle > 90° occurred in 20.9%, 13.6%, and 8.2% of patients, respectively. The low prevalence of these findings is explored below.
Prominent left atrial appendage (third contour)
This sign was most prevalent in our cohort. The sensitivity, specificity, and accuracy were 21.2%, 80.0%, and 34.6%, respectively, indicating low overall diagnostic performance. Prior work demonstrated better accuracy in mitral valve disease, particularly rheumatic heart disease.19,20 No patients in our cohort had rheumatic
heart disease. In nonrheumatic LAE, pulmonary artery prominence and ventricular enlargement may obscure the left atrial appendage shadow, rendering the sign undetectable.
Double density sign
The double density sign in the right retrocardiac area showed sensitivity of 11.8%, specificity of 80.0%, and accuracy of 21.3%. Its low prevalence contrasts with prior work; Higgins et al reported universal presence in patients with echocardiographic LAE. Interpretation challenges and variable film quality likely contributed. A curvilinear line over the right cardiac shadow can appear without cardiac disease, while adjacent structures, particularly the right pulmonary vein, can mimic the left atrial border, explaining the interstudy differences.
Widened subcarinal angle
Despite the high prevalence of LAE, only 8.2% of patients had a subcarinal angle > 90°. The sensitivity, specificity, and accuracy were 8.2%, 92.0%, and 27.3%, respectively. This likely reflects that 90° represents the upper limit of normal reported previously21, so many patients with LAE have angles < 90°. Reported thresholds vary across studies22,23, likely due to difficulty plotting the left main bronchus axis as it courses beneath the aortic arch. Using a lower cutoff of > 75° increased the proportion of patients meeting the angle criterion to 42.7%, with sensitivity, specificity, and accuracy of 41.2%, 52.0%, and 43.6%, respectively.
When any one of the 3 CXR criteria was considered positive, sensitivity was high but specificity was unacceptably low. Conversely, requiring all 3 criteria yielded high specificity but unacceptably low sensitivity. With all 3 criteria combined, sensitivity was 8.2% using the > 75° angle threshold and 3.5% using the > 90° threshold, while specificity reached 88.0% and 96.0%, respectively. The study found that the sensitivity and specificity of classical CXR signs for LAE were low. Whether combination of other parameter such as electrocardiogram findings
would improve the outcomes is not known.
CONCLUSIONS
This study demonstrated limited diagnostic performance of conventional radiographic signs. Despite its accessibility and routine use, CXR showed low sensitivity and specificity compared with CMR.
This study has several limitations. First, the enrolled population had a high prevalence of LAE, which may
Factor
Sex
BMI
Age
TABLE 5. Factors associated with CXR parameters (sex, BMI, age).
Male | Female | p- value | Mean ± SD | p - value | Mean ± SD | p - value | |
X-ray parameter | |||||||
3rd Contour | |||||||
0 | 11 (55.0%) | 9 (45.0%) | 0.306 | 24.1 ± 3.7* | 0.018 | 68.4 ± 13.0 | 0.958 |
1 | 24 (35.8%) | 43 (64.2%) | 26.8 ± 5.3** | 68.8 ± 9.1 | |||
2 | 9 (39.1%) | 14 (60.9%) | 24.5 ± 3.3 | 69.4 ± 10.8 | |||
3rd Contour | |||||||
0 | 11 (55.0%) | 9 (45.0%) | 0.130 | 24.1 ± 3.7 | 0.074 | 68.4 ± 13.0 | 0.866 |
1 - 2 | 33 (36.7%) | 57 (63.3%) | 26.2 ± 4.9 | 68.9 ± 9.5 | |||
3rd Contour | |||||||
0 - 1 | 35 (40.2%) | 52 (59.8%) | 0.924 | 26.1 ± 5.1 | 0.135 | 68.7 ± 10.0 | 0.766 |
2 | 9 (39.1%) | 14 (60.9%) | 24.5 ± 3.3 | 69.4 ± 10.8 | |||
Double density sign | |||||||
0 1 | 38 (40.0%) 6(40.0%) | 57 (60.0%) 9 (60.0%) | 1.00 | 25.5 ± 4.3 27.9 ± 6.9 | 0.211 | 68.6 ± 9.9 70.3 ± 11.9 | 0.539 |
Subcarinal ≤ 75 | angle 29 (46.0%) | 34 (54.0%) | 0.135 | 25.1 ± 4.7 | 0.058 | 69.6 ± 10.4 | 0.336 |
| 15 (31.9%) | 32 (68.1%) | 26.8 ± 4.7 | 67.7 ± 9.8 | |||
≤ 90 | 41 (40.6%) | 60 (59.4%) | 0.739 | 25.4 ± 4.5 | 0.011 | 68.8 ± 10.2 | 0.877 |
| 3 (33.3%) | 6 (66.7%) | 29.6 ± 6.2 | 69.3 ± 9.9 | |||
Subcarinal angle >75 & Double density sign & 3rd Contour | |||||||
0 1 | 40 (40.0%) 60 (60.0%) 4 (40.0%) 6 (60.0%) | 1.00 | 25.6 ± 4.6 27.3 ± 6.5 | 0.302 | 68.9 ± 10.1 68.3 ± 11.7 | 0.864 | |
Subcarinal | angle >90 & Double density sign | & 3rd Contour | |||||
0 1 | 42 (39.6%) 2 (50.0%) | 64 (60.4%) 2 (50.0%) | 1.00 | 25.6 ± 4.5 30.6 ± 9.1 | 0.351 | 68.8 ± 10.1 70.5 ± 11.9 | 0.739 |
Carinal | Angle >75 or Double | Contour or 4th Curve | |||||
0 1 | 7 (15.9%) 37 (84.1%) | 6 (9.1%) 60 (90.9%) | 0.278 | 23.7 ± 4.4 26.1 ± 4.8 | 1.00 | 71.1 ± 11.7 68.5 ± 10.0 | 0.397 |
Subcarinal | angle >90 or | Double density sign | or 3rd Contour | ||||
0 1 | 10 (22.7%) 34 (77.3%) | 9 (13.6%) 57 (86.4%) | 0.217 | 24.2 ± 3.7 26.1 ± 4.9 | 0.103 | 67.6 ± 12.8 69.1 ± 9.6 | 0.647 |
*p-value < 0.05 of Multiple comparison between 3rd Contour (0) vs 3rd Contour (1).
**p-value < 0.05 of Multiple comparison between 3rd Contour (1) vs 3rd Contour (2).
have influenced the diagnostic performance of CXR parameters; including more patients with normal left atrial size would improve generalizability. Second, CXRs were performed within 6 months of CMR rather than on the same day; however, only clinically stable patients were included to minimize temporal variation. Third, analysis was restricted to posteroanterior views; adding lateral views might have improved sensitivity. Finally, image interpretation by 2 experienced cardiologists may not capture interobserver variability across a broader range of readers.
The datasets generated and analyzed during the current study are not publicly available due to patient confidentiality but are available from the corresponding author on reasonable request.
ACKNOWLEDGMENT
The authors thank Ms. Khemajira Karaketklang for her valuable assistance with statistical analysis.
DECLARATIONS
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
The authors declare that there are no conflicts of interest.
Not applicable.
Conceptualization and methodology, S.P, M.M., and T.B. ; Investigation, S.P, M.M., and T.B. ; Formal analysis, S.P, M.M., and T.B. ; Visualization and writing – original draft, S.P. and T.B. ; Writing – review and editing, S.P, M.M., and T.B. ; Funding acquisition, S.P, M.M., and T.B. ; Supervision, S.P, M.M., and T.B. All authors have read and agreed to the final version of the manuscript.
The authors did not use any generative artificial intelligence tools in the preparation, writing, or analysis of this manuscript.
The study protocol was approved by the Siriraj Institutional Review Board, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (731/2554 [EC3]).
REFERENCES
Haykal R, Kassar A, Chamoun N, Akoum N. The left atrium in heart failure with preserved ejection fraction: What we know and what we do not know. Heart Rhythm O2. 2025;6(7):1028–38.
Thomas L, Abhayaratna WP. Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance. JACC Cardiovasc Imaging. 2017;10(1):65–77.
Janwanishstaporn S, Boonyasirinant T. Correlation between aortic stiffness and left atrial volume index in hypertensive patients. Clin Exp Hypertens. 2016;38(2):160–5.
Jaturapisanukul S, Kaolawanich Y, Meechuen M, Boonyasirinant
T. Correlation between Obesity and Left Atrial Enlargement in Patients Using Cardiac Magnetic Resonance. Siriraj Med J. 2025;77(2):130–6.
Higgins CB, Reinke RT, Jones NE, Broderick T. Left atrial dimension on the frontal thoracic radiograph: a method for assessing left atrial enlargement. AJR Am J Roentgenol. 1978; 130(2):251–5.
Quinton SJ, Ker JA, Rheeder P, Deffur A. The reliability of chest radiographs in predicting left atrial enlargement. Cardiovasc J Afr. 2010;21(5):274–9.
El Mathari S, Hopman L, Bouchnaf C, Heidendael JF, Nederveen AJ, van Ooij P, et al. Clinical implications of different methods to assess left atrial remodeling: A comparative study between echocardiography and cardiac magnetic resonance imaging for left atrial volume index quantification. Int J Cardiol. 2024;414:132443.
Maceira AM, Cosín-Sales J, Roughton M, Prasad SK, Pennell DJ. Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 2010;12(1):65.
Mahmod M, Bull S, Kailayanathan T, Davis TA, Borlotti A, Popescu IA, et al. Left atrial volume quantification by transthoracic echocardiography versus cardiovascular magnetic resonance: a systematic review and meta-analysis. Int J Cardiovasc Imaging. 2025;41(9):1657–69.
Cho MS, Park HS, Cha MJ, Lee SR, Park JK, Kim TH, et al. Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation. Sci Rep. 2021;11(1):23808.
Khan MA, Yang EY, Zhan Y, Judd RM, Chan W, Nabi F, et al. Association of left atrial volume index and all-cause mortality in patients referred for routine cardiovascular magnetic resonance: a multicenter study. J Cardiovasc Magn Reson. 2019;21(1):4.
Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R, Lakkireddy D, et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace. 2018;20(1):33–42.
Essayagh B, Antoine C, Benfari G, Messika-Zeitoun D, Michelena H, Le Tourneau T, et al. Prognostic Implications of Left Atrial Enlargement in Degenerative Mitral Regurgitation. J Am Coll Cardiol. 2019;74(7):858–70.
Tsao CW, Josephson ME, Hauser TH, O’Halloran TD, Agarwal A, Manning WJ, et al. Accuracy of electrocardiographic criteria
for atrial enlargement: validation with cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10(1):7.
Bureekam S, Boonyasirinant T. Accuracy of left atrial enlargement diagnosed by electrocardiography as compared to cardiac magnetic resonance in hypertensive patients. J Med Assoc Thai. 2014;97 Suppl 3:S132–8.
Matsuda M, Matsuda Y. Mechanism of left atrial enlargement related to ventricular diastolic impairment in hypertension. Clin Cardiol. 1996;19(12):954–9.
Cioffi G, Mureddu GF, Stefenelli C, de Simone G. Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens. 2004;22(8): 1589–96.
Eshoo S, Ross DL, Thomas L. Impact of mild hypertension on left atrial size and function. Circ Cardiovasc Imaging. 2009;2(2):93–9.
Kelley MJ, Elliott LP, Shulman ST, Ayoub EM, Victorica BE, Gessner IH. The significance of the left atrial appendage in rheumatic heart disease. Circulation. 1976;54(1):146–53.
Kaye J, Meyer MJ, Van Lingen B, McGregor M, Braudo JL. The radiological diagnosis of mitral valve disease. Br J Radiol. 1953;26(305):242–51.
Murray JG, Brown AL, Anagnostou EA, Senior R. Widening of the tracheal bifurcation on chest radiographs: value as a sign of left atrial enlargement. AJR Am J Roentgenol. 1995;164(5): 1089–92.
Alavi SM, Keats TE, O’Brien WM. The angle of tracheal bifurcation: its normal mensuration. Am J Roentgenol Radium Ther Nucl Med. 1970;108(3):546–9.
Haskin PH, Goodman LR. Normal tracheal bifurcation angle: a reassessment. AJR Am J Roentgenol. 1982;139(5):879–82.